Corteva Targets $1B+ Seed R&D and Gene-Edited Products in India After Split
After its split into two listed entities, Corteva Agrisciences says it wants to keep about $1 billion a year or more in R&D for the seeds business through the new Vylor unit. The company plans to bring gene-edited products into India, supported by growing licensing, while seeking a stable regulatory outlook under India’s Seeds Bill.